1. Home
  2. |Insights
  3. |The Antitrust Compliance in Pharmaceutical Companies

The Antitrust Compliance in Pharmaceutical Companies

Event | 09.30.08, 12:00 AM UTC - 12:00 AM UTC

This meeting addresses:

  • Current developments in view of investigations by the European Commission
  • Licensing and distribution strategies at the interface to antitrust law
  • Conduct and preventive measures in pharmaceutical companies

Werner Berg is speaking at this conference. The topic is "How do I behave with dawn raids"?

Insights

Event | 12.04.25

ACI 30th Annual Conference on Drug & Medical Device Litigation

Dan Campbell with Speak on the panel "Mastering MDL Case Management: What Proposed Rule 16.1 Really Means for Consolidated Litigation."
Rule 16.1 attempts to guide early case management in MDLs, impacting litigation pace and costs. Permissive language like “should” instead of “must”, could lead to inconsistent applications. This panel will explore the rule’s anticipated impact and implications for procedures.